收费全文 | 4187篇 |
免费 | 269篇 |
国内免费 | 24篇 |
耳鼻咽喉 | 30篇 |
儿科学 | 133篇 |
妇产科学 | 87篇 |
基础医学 | 556篇 |
口腔科学 | 120篇 |
临床医学 | 327篇 |
内科学 | 1036篇 |
皮肤病学 | 59篇 |
神经病学 | 350篇 |
特种医学 | 117篇 |
外科学 | 705篇 |
综合类 | 21篇 |
预防医学 | 325篇 |
眼科学 | 56篇 |
药学 | 231篇 |
中国医学 | 25篇 |
肿瘤学 | 302篇 |
2023年 | 28篇 |
2022年 | 70篇 |
2021年 | 134篇 |
2020年 | 78篇 |
2019年 | 119篇 |
2018年 | 144篇 |
2017年 | 80篇 |
2016年 | 101篇 |
2015年 | 124篇 |
2014年 | 149篇 |
2013年 | 179篇 |
2012年 | 338篇 |
2011年 | 322篇 |
2010年 | 194篇 |
2009年 | 139篇 |
2008年 | 270篇 |
2007年 | 293篇 |
2006年 | 261篇 |
2005年 | 230篇 |
2004年 | 226篇 |
2003年 | 249篇 |
2002年 | 232篇 |
2001年 | 48篇 |
2000年 | 34篇 |
1999年 | 41篇 |
1998年 | 33篇 |
1997年 | 20篇 |
1996年 | 26篇 |
1995年 | 19篇 |
1994年 | 17篇 |
1993年 | 15篇 |
1992年 | 32篇 |
1991年 | 21篇 |
1990年 | 26篇 |
1989年 | 20篇 |
1988年 | 19篇 |
1987年 | 15篇 |
1986年 | 19篇 |
1985年 | 11篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 15篇 |
1981年 | 8篇 |
1980年 | 5篇 |
1978年 | 8篇 |
1976年 | 4篇 |
1975年 | 5篇 |
1974年 | 4篇 |
1973年 | 6篇 |
1971年 | 4篇 |
Areas covered: The American Joint Committee on Cancer (AJCC) updated breast cancer staging in 2016 to include T, N, M, tumor grade and expression of estrogen and progesterone receptors and HER2. Addition of these factors changed the stage group for a large fraction of cases compared to prior TNM stage groupings. This updated ‘prognostic stage’ provides more robust and precise prognosis information.
Expert opinion: Inclusion of biological information in staging changes the meaning and the use of stage in clinical practice. This paper reviews the evidence supporting these changes, limitations affecting staging, and discusses the implications for clinical practice and the future of breast cancer staging. 相似文献
Background
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.Objective
To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.Design, setting, and participants
A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.Outcome measurements and statistical analyses
Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.Results and limitations
Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).Conclusions
Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.Patient summary
We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI. 相似文献Although calibration slopes differed with the two types of analysis and the different lyophilized plasmas, both gave reasonable approximations to fresh plasma ISI calibrations. With orthogonal regression the overall percentage INR deviation was 5.25% with the artificially depleted plasmas and 6.85% for the results with lyophilized coumarins. With the linear regression, deviation was 8.40% for the artificially depleted plasmas and 5.05% for coumarin-treated patients' lyophilized plasmas. The simpler regression method appears to be worthy of further study as the present report has demonstrated that if the calibrant plasmas are accurately certified with the thromboplastin International Reference Plasma (IRP) results approximate to the conventionally determined INR using the manual PT technique. Coagulometers require further assessment. 相似文献